Israeli Scientists Develop Highly Accurate Early Breast Cancer Blood Test
Summarized from Israel National News by baba
Israeli researchers have developed an experimental blood test that detects early-stage breast cancer with 95% accuracy, overcoming limitations of mammography, especially for dense breast tissue. The test also predicts cancer recurrence with 81% accuracy by identifying aggressive cell signatures. While still experimental, the breakthrough could lead to improved diagnostics and preventative treatments.
The story in 6 lines · by baba
- An experimental blood test developed by Israeli scientists detects early breast cancer with 95% accuracy.
- The test identifies chemical markers released by disintegrating cancer cells using AI and advanced microscopy.
- It can detect tumors smaller than two centimeters that have not spread beyond the breast.
- Researchers predict cancer recurrence with 81% accuracy by identifying aggressive cell signatures.
- The test's performance is not affected by breast density, a common mammography challenge.
- The blood test is currently experimental and not yet available for routine screening.
Israel National News publishes in English. The key points are summarized above. Read Israel National News’s full report from the link at the top of the page.
Mentioned